Skip to main content
Clinical Trials/ACTRN12611000843954
ACTRN12611000843954
Recruiting
未知

Investigating changes in hippocampal volume and regional cerebral perfusion and therapeutic and system related outcomes (including symptom reduction and effects of participants experience of therapy on treatment efficacy, daily functioning and quality of life) following the treatment of Post Traumatic Stress Disorder with eye movement desensitization and reprocessing (EMDR) and prolonged exposure therapy: a pilot study.

Murdoch University0 sites20 target enrollmentAugust 10, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Murdoch University
Enrollment
20
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Currently diagnosable with PTSD (via assessment interview and CAPS form 2\); willing to engage in psychological treatment; consenting to neuroimaging and audio\-taped interviews.

Exclusion Criteria

  • Current drug or alcohol dependence; diabetes; currently pregnant or breast feeding; past history of psychotic illness; previously diagnosed organic brain disorder; evidence of diagnosable cluster B Personality Disorder (via SCID II); currently on Psychotropic based medications; unable to cope with confined spaces or needles; any metal implants.

Outcomes

Primary Outcomes

Not specified

Similar Trials